ATE114311T1 - Bivalente liganden, wirksam für die blockierung des enzyms acat. - Google Patents

Bivalente liganden, wirksam für die blockierung des enzyms acat.

Info

Publication number
ATE114311T1
ATE114311T1 AT89907579T AT89907579T ATE114311T1 AT E114311 T1 ATE114311 T1 AT E114311T1 AT 89907579 T AT89907579 T AT 89907579T AT 89907579 T AT89907579 T AT 89907579T AT E114311 T1 ATE114311 T1 AT E114311T1
Authority
AT
Austria
Prior art keywords
blocking
bivalent ligands
acat
ligands effective
enzyme acat
Prior art date
Application number
AT89907579T
Other languages
English (en)
Inventor
Ronald B Gammill
Frank P Bell
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Application granted granted Critical
Publication of ATE114311T1 publication Critical patent/ATE114311T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D519/00Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/0803Compounds with Si-C or Si-Si linkages
    • C07F7/081Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te
    • C07F7/0812Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te comprising a heterocyclic ring
    • C07F7/0814Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te comprising a heterocyclic ring said ring is substituted at a C ring atom by Si

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT89907579T 1988-08-16 1989-06-16 Bivalente liganden, wirksam für die blockierung des enzyms acat. ATE114311T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US23293188A 1988-08-16 1988-08-16

Publications (1)

Publication Number Publication Date
ATE114311T1 true ATE114311T1 (de) 1994-12-15

Family

ID=22875168

Family Applications (1)

Application Number Title Priority Date Filing Date
AT89907579T ATE114311T1 (de) 1988-08-16 1989-06-16 Bivalente liganden, wirksam für die blockierung des enzyms acat.

Country Status (7)

Country Link
EP (1) EP0429464B1 (de)
JP (1) JPH04500506A (de)
KR (1) KR900701792A (de)
AT (1) ATE114311T1 (de)
DE (1) DE68919475T2 (de)
DK (1) DK25691A (de)
WO (1) WO1990002129A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5304548A (en) * 1988-08-16 1994-04-19 The Upjohn Company Bivalent ligands effective for blocking ACAT enzyme for lowering plasma triglycerides and for elevating HDL cholesterol
US5180717A (en) * 1988-08-16 1993-01-19 The Upjohn Company Bivalent ligands effective for blocking ACAT enzyme for lowering plasma triglycerides and for elevating HDL cholesterol
WO1995027964A1 (en) * 1994-04-12 1995-10-19 Qualcomm Incorporated Method and apparatus for freight transportation using a satellite navigation system
WO2009038064A1 (ja) * 2007-09-19 2009-03-26 Institute Of Medicinal Molecular Design, Inc. I型11βヒドロキシステロイド脱水素酵素阻害活性を有する複素環誘導体
AU2009221179A1 (en) * 2008-03-05 2009-09-11 Boehringer Ingelheim International Gmbh Tricyclic pyridine derivatives, medicaments containing such compounds, their use and process for their preparation
SG183321A1 (en) 2010-02-19 2012-09-27 Boehringer Ingelheim Int Tricyclic pyridine derivatives, medicaments containing such compounds, their use and process for their preparation
WO2013024130A1 (en) 2011-08-17 2013-02-21 Boehringer Ingelheim International Gmbh Furo[3,4-c]quinoline derivatives, medicaments containing such compounds, their use and process for their preparation
CN107021940A (zh) * 2017-05-03 2017-08-08 天津国际生物医药联合研究院 一种双哌嗪类化合物及其应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU529561B2 (en) * 1979-02-13 1983-06-09 Upjohn Company, The Antiatherogenic 6-halofurochromones
US4412071A (en) * 1982-05-17 1983-10-25 The Upjohn Company Antiatherosclerotic compositions

Also Published As

Publication number Publication date
AU3835889A (en) 1990-03-23
EP0429464B1 (de) 1994-11-23
DK25691D0 (da) 1991-02-14
AU631801B2 (en) 1992-12-10
EP0429464A1 (de) 1991-06-05
DE68919475D1 (de) 1995-01-05
DE68919475T2 (de) 1995-05-11
JPH04500506A (ja) 1992-01-30
KR900701792A (ko) 1990-12-04
DK25691A (da) 1991-02-14
WO1990002129A1 (en) 1990-03-08

Similar Documents

Publication Publication Date Title
ATE104380T1 (de) Sauerstoffdelignifizierung und enzymatische behandlung.
TR199501643A2 (tr) Yünün enzimlerle tedavisi icin yöntem.
NO881697D0 (no) Verktoeyenhet, verktoeydeler og fremgangsmaate for sammensetting av delene.
WO2001049830A3 (en) Improved lysosomal enzymes and lysosomal enzyme activators
NO910923D0 (no) Trifunksjonell antistofflignende forbindelse som et kombinert diagnostisk og terapeutisk middel.
DE68917729D1 (de) Reinigung und verabreichung von dns-reparatur-enzymen.
DE68924026D1 (de) Biosensor und dessen herstellung.
DE3783626D1 (de) Detergens-bleichmittelzusammensetzungen, bleichmittelzusammensetzungen und bleichmittelaktivatoren.
WO1996021730A3 (en) Ribozymes with rna protein binding site
NO872376D0 (no) Eksoterm, ledende pasta og anvendelse av denne.
ITVI940016A0 (it) Chiusura per bracciali, collane e simili.
DE3873992D1 (de) Blutfetterniedrigende und antiatherosclerotische harnstoff-verbindungen.
DE3788691D1 (de) Verhütung von Fusariumkrankheiten und Mikroorganismen dafür.
NO900607L (no) Enzymatisk oppvaskmiddel.
ATE114311T1 (de) Bivalente liganden, wirksam für die blockierung des enzyms acat.
ES8609468A1 (es) Un procedimiento para preparar un derivado de una enzima fibronolitica
DE69613329D1 (de) Enzym enthaltendes Granulat, Herstellungsmethode und das Granulat enthaltende Zusammensetzungen
NO994858L (no) Forbindelser og preparater til behandling av sykdommer assosiert med serinprotease, spesielt tryptase aktivitet
DE3763814D1 (de) Enzyme enthaltendes geschirrwaschmittel.
DE3780506D1 (de) Reinigung des einkettigen und zweikettigen gewebeplasminogenaktivators.
NO871844D0 (no) Strikkede stoffer og fremgangsmaate for fremstilling av disse.
NO892505L (no) Behandling av vandige dispersjoner.
LV12149A (lv) 5-Aizvietoti mikofenolskabes 4-aminoatvasinajumi
NO168055C (no) Fremgangsmaate for fremstilling av human vevplasminogenaktivator og urokinase-type plasminogenaktivator.
NO970140D0 (no) Technetium-sulfonamidkomplekser, deres anvendelse, farmasöytiske midler inneholdende disse, samt fremgangsmåte for fremstilling av kompleksene og midlene

Legal Events

Date Code Title Description
REN Ceased due to non-payment of the annual fee